Abstract
There is growing evidence that bone marrow transplantation is an effective means of treating solid tumors in the pediatric age group. Conventional chemoradiotherapy, in which the dose is limited by the degree of bone marrow suppression, does not increase long-term survival for most disseminated neoplasms. Bone marrow transplantation utilizes high-dose chemoradiotherapy without regard to marrow toxicity and may be the treatment of choice for these malignancies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Franklin I, Pritchard J. Detection of bone marrow invasion by neuroblastoma is improved by sampling at two sites with both aspirates and trephine biopsies. J Clin Pathol 1983; 36:1215–1218.
Brunning R, Bloomfield C, McKenna R, Peterson L. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 1975; 82:365–6.
Hirsch F, Hansen H, Hainau B. Bilateral bone-marrow examinations in small-cell anaplastic carcinoma of the lung. Acta Path Microbiol Scand 1979; 87A:59–62.
Moss TJ, Seeger RC, Kindler-Rohrborn A, Marangos PJ, Rajewsky MF, Reynolds, CP. Immunohistologic detection and phenotyping of neuroblastoma cells in bone marrow using cytoplasmic neuron specific enolase and cell surface antigens. Prog Clin Biol Res 1975; 175:367–378.
Evans AE, Griffin GC, Tartaglione M, Kennett RH. A method of detecting neuroblastoma in human bone marrow by means of two monoclonal antibodies PI 153/3 and KE2. Hybridoma 1985; 4:289–296.
Cheung NV, Van Hoff DD, Strandjord SE, Coccia PF. Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies. J Clin Oncol 1986; 4:363–369.
Redding WH, Monaghan P, Imrie SF, Ormerod MG, Gazet J, Coombes RC, Clink FM, Dearnaley DP, Sloane JP, Powles TJ, Neville Am. Detection of micrometastases in patients with primary breast cancer. Lancet 1983; 2:1271–1273.
Stahel RA, Mabry M, Skarkin AT, Speak J, Bernai SD. Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol 1985; 3:455–461.
Moss TJ, Reynolds, CP, Reisfeld RA, Sather H, Hammond D, Seeger RC. Sensitive immunohistologic detection of neuroblastoma cells in bone marrow using monoclonal antibodies. Clin Res 1986; 35:230a.
Cecchetto G, Luzzatto C, Carli M, Guglieimi M, Zanesco L. The role of Surgery in non-localized neuroblastoma. Analysis of 59 cases. Tumori 1983; 69:327–329.
Grosfeld JL, Ballantine TVN, Baehner RL. Experience with ‘second-look’ operations in pediatric solid tumors. J Ped Surg 1978; 13:275–280.
Grosfeld JL, Schatzlein M, Ballantine TVN, Weetman RM, Baehner RL. Metastatic neuroblastoma: Factors influencing survival. J Ped Surg 1978; 13:59–65.
Smith EI, Krous HF, Tunell WP, Hitch DC. The impact of chemotherapy and radiation therapy on secondary operations for neuroblastoma. Ann Surg 1980; 191:561–568.
Moss TJ, Fonkalsrud E, Feig SA, Lenarsky C, Selch M, Wells M, Seegar RC. Delayed surgery and bone marrow transplantation for widespread neuroblastoma. Ann Surg 1987; 206:514–521.
Foglia RP, Fonkalsrud EW, Feig SA, Moss TJ. Accuracy of diagnostic imaging as determined by delayed operative intervention for advanced neuroblastoma. J Ped Surg, 1989, in press.
Matthay KK, Moss TJ, Xu Z, Siegel SE, Finkelstein JZ, Seeger RC. Length of induction therapy is critical for preparing patients with advanced neuroblastoma (NBL) for bone marrow transplantation (BMT). Proc Soc Clin Oncol 1988; 7:257.
Moss TJ, Xu G, Rayner SA, Wells J, Reynolds CP, Heitjan D, Seeger RC. Immunohisto-logic detection of infrequent neuroblastoma (NB) cells and autologous bone marrow transplantation (BMT). Proc Am Assoc Cancer Res 1987; 28:219.
Graeve JLA, de Alarcon PA, Sato Y, Pringle K, Helson L. Miliary pulmonary neuroblastoma: A risk of autologous bone marrow transplantation? Cancer 1988; 62: 2125–2127.
Glorieux, Bouffet E, Philip I, Biron P, Holzapfel L, Floret D, Bouvier R, Vitrey D, Pinkerton R, Brunat-Mentigny M, Philip T. Metastatic interstitial pneumonitis after autologous bone marrow transplantation. A consequence of reinjection of maligant cells? Cancer 1986; 58:2136–2139.
Medenica RD, Nava EF, Freeman AI. Diffuse pulmonary infiltration of neuroblastoma following autologous bone marrow transplantation. Blood 1985; 66:261a.
Philip T, Zucker JM, Bernard JL, Biron P, Kremens B, Quintana E, Gentet JC, Bordigoni P, Frappaz D, Souillet G, Philip I, Chauvin F, Favrot M. Bone marrow transplantation in an unselected group of 65 patients with stage IV neuroblastoma. In: Autologous Marrow Transplantation: Proceedings of the Third International Symposium, Dicke KA, Spitzer G, Jagannath S, eds. MD Anderson Hospital and Tumor Institute, Houston, 1987:407–417.
Sharkis SJ, Santos GW, Colvin M. Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide Blood 1980; 55:521–523.
Rizzoli V, Mangoni L, Degliantoni G, Porcellini A, Carella AM, Alessandrino EP, Aglietta M, Torlontano G, Coleselli P, Mozzana A, Madon E, Resegotti L. Autologous bone marrow transplantation in acute lymphocytic leukemia. In: Autologous Marrow Transplantation: Proceedings of the Third International Symposium, Dicke KA, Spitzer G, Jagannath S, eds. MD Anderson Hospital and Tumor Institute, Houston, 1987:35–42.
Wada R, Seeger RC, Brodeur G, Slamon D, Rayner S, Tomayko M, Reynolds CP. Neuroblastoma cell lines that express one copy of the N-myc oncogene. Prog Clin Biol Res 1988; 271:57–59.
Yeager AM, Kaizer H, Colvin OM, Rowley SD, Braine HG, Stuart RK, Sarai R, Santos GW. Autologous bone marrow transplanation in acute nonlymphocytic leukemia using marrow treated with 4-hydroperoxycyclophosphamide. In: Autologous Marrow Transplantation: Proceedings of the Third International Symposium, Dicke KA, Spitzer G, Jagannath S, eds. MD Anderson Hospital and Tumor Institute Houston, 1987:59–68.
Takvorian T, Canellos GP, Ritz J, Freedman AS, Anderson kc, Mauch P, Tarbell N, Coral F, Daley H, Yeap B, Schlossman SF, Nadler LM. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin’s lymphoma with a poor prognosis. N Engl J Med 1987; 316:1499–1505.
Coombes RC, Buckman R, Forrester JA, Shepherd V, O’Hare MJ, Vincent M, Powles TJ, Neville AM. In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplanation for patients with breast cancer. Cancer Res 1986; 46:4217–4220.
Hartmann O, Benhamou E, Beaujean F, Kalifa C, Lejars O, Patte C, Behard C, Flamant F, Thyss A, Deville A, Vannier JP, Pautard-Muchemble B, Lemerle J. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma. J Clin Oncol 1987; 5:1205–1211.
Macfarlane SD, Tauro GP, Rendall K, Welch JJ, Ekert H. Isolation of malignant cells from human bone marrow using a discontinuous Percoll gradient. Am J Hematol 1986; 22:403–407.
Figdor CG, Voute PA, de Kraker J, Vernie LN, Bont WS. Physical cell separation of neuroblastoma cells from bone marrow. Prog Clin Biol Res 1985; 175:459–470.
Seeger RC, Reynolds CP, Moss TJ, Lenarsky C, Feig SA, Selch M, Ugelstad J, Wells J. Autologous bone marrow transplantation for poor prognosis neuroblastoma. In: Autologous Marrow Transplantation: Proceedings of the Third International Symposium, Dicke K, Spitzer G, Zander A, eds. MD Anderson Hospital and Tumor Institute, Houston, 1987: 375–382.
Anderson KC, Ritz J, Takvorian T, Coral F, Daley H, Gorgone BC, Freedman AS, Candios GP, Schlossman SF, Nadler LM. Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow. Blood 1987; 69:597–604.
Greenberger JS, Rothstein L, DeFabritiis P, Bregni M, Bast R Jr, Ritz J, Nadler LM, Lipton JM, Sakakeeny MA. Effects of monoclonal antibody and complement treatment of human marrow on hematopoiesis in continuous bone marrow culture. Cancer Res 1985; 45:758–767.
Bast RC Jr, DeFabritiis P, Lipton J, Gelber R, Maver C, Nadler L, Sallan S, Ritz J. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Cancer Res 1985; 45:499–503.
Gee A, VanHilten J, Graham-Pole J, Boyle MDP. Antibody-complement mediated killing of neuroblastoma cells. Prog Clin Biol Res 1984; 175:471–483.
Treleaven LG, Kemshead JT. Removal of tumur cells from bone marrow: An evaluation of the available techniques. Hematol Oncol 1985; 3:65–75.
Saarinen UM, Coccia PF, Gerson SL, Pelley R, Cheung NV. Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: Method for purging autologous bone marrow. Cancer Res 1985; 45:5969–75.
Bregni M, DeFabritiis P, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC Jr. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody: ricin A chain conjugates. Cancer Res 1986; 46:1208–1213.
Muirhead M, Martin PJ, Torok-Storb B, Uhr JW, Vitetta ES. Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow. Blood 1983; 62:327–332.
Tai J, Blair AH, Ghose T. Tumour inhibition by chlorambucil covalently linked to anti-tumour globulin. Eur J Cancer 1979; 15:1357–1363.
Bernier LG, Page M, Gaudreault RC, Joly LP. A chlorambucil-anti-CEA conjugate cytotoxic for human colon adenocarcinoma cells in vitro. Br J Cancer 1984; 49:245–246.
Embleton MJ, Rowland GF, Simmonds RG, Jacobs E, Marsden CH, Baldwin RW. Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugate. Br J Cancer 1983; 47:43–49.
Bragman KS, Heath TD, Papahadjopoulos D. Simultaneous interaction of monoclonal antibody-targeted liposomes with two receptors on K562 cells. Biochim Biophys Acta 1983; 730:187–195.
Favrot M, Philip I, Combaret V, Maritza O, Philip T. Experimental evaluation of an im-munomagnetic bone marrow purging procedure using the Burkitt lymphoma model. Bone Marrow Transpl 1987; 2:59–66.
Kemshead JT, Heath L, Gibson FM, Katz F, Richmond F, Treleaven J, Ugelstad J. Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: Experience, improvements and observations. Br J Cancer 1986; 54:771–778.
Reynolds CP, Seeger RC, Vo DD, Black ST, Wells J, Ugelstad J. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Cancer Res 1986; 46:5882–5886.
Seeger RC, Reynolds CP, Vo DD, Ugelstad J, Wells J. Depletion of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads. Prog Clin Biol Res 1985; 175:443–458.
Treleaven JG, Gibson FM, Ugelstad J, Rembaum A, Philip T, Caine GD, Kemshead JT. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet 1984; 1:70–73.
Seeger RC, Moss TJ, Feig SA, Lenarsky C, Selch M, Ramsay N, Harris R, Wells J, Sather H, Reynolds CP. Bone marrow transplantation for poor prognosis neuroblastoma. Prog Clin Biol Res 1988; 271:203–213.
Gee AP, Graham-Pole J, Lee C, Bruce K, Pick T, Harvey W, Worthington-White D, Hintz M, Janssen W, Gross S. Transplantation for neuroblastoma using immunomagnetically purged autologous bone marrow. In: Autologous Marrow Transplantation: Proceedings of the Third International Symposium, Dicke KA, Spitzer G, Jagannath S, eds. MD Anderson Hospital and Tumor Institute, Houston, 1987:425–431.
Ades EW, Peacocke N, Sabio H. Lymphokine-activated killer cell lysis of human neuroblastoma cells: A model for purging tumor cells from bone marrow. Clin Immunol and Immunopath 1988; 46:150–156.
Reisner Y, Kapoor N, Kirkpatrick D, Pollack M, Dupont B, Good R, O’Reilly R. Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 1981; 2:327–331.
Elkins WL. Preliminary studies of lectin agglutination of metastatic neuroblastoma. Prog Clin Biol Res 1984; 175:405–411.
De Fabritiis P, Bregni M, Lipton J, Greenberger J, Nadler L, Rothstein L, Korbling M, Ritz J, Bast RC Jr. Elimination of clonogenic Burkitt’s lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement. Blood 1985; 65:1064–1070.
Jones RJ, Zuehlsdorf M, Rowley SD, Hilton J, Santos GW, Sensenbrenner LL, Colvin OM. Variability in 4-hydroperoxycyclophosphamide activity during clinical pruging for autologous bone marrow transplantation. Blood 1987; 70:1490–1494.
Kaizer H, Stuart RK, Brookmeyer R, Beschorner WE, Braine HG, Burns WH, et al. Autologous bone marrow transplantation in acute leukemia: A phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood 1985; 65:1504–1510.
Bruchelt G, Buck J, Girgert R, Treuner J, Niethammer D. The role of reactive oxygen compounds derived from 6-hydroxydopamine for bone marrow purging from neuroblastoma cells. Biochim Biophys Res Comm 1985; 130:168–174.
Helson L, Clarkson B, Langleben A, Helson C, O’Reilly RD, Gulati S. Purging neuroblastoma cells from human bone marrow. Eur J Cancer 1982; 18(10): 1043.
Reynolds CP, Perez-Polo JR. Ascorbic acid enhances the cytotoxic effect of 6-hydroxydopamine for human neuroblastoma cell lines. Neurosci Lett 1981; 26:151–155.
Reynolds GP, Reynolds DA, Frenkel EP, Smith RG. Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: A model for clearing marrow prior to autologous transplant. Cancer Res 1982; 42:1331–1336.
Pinkerton CR, Philip T, Biron P, Frapazz D, Phillipe N, Zucker JM, Bernard JL, Philip I, Kemshead J, Favrot M. High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoms: A phase II study. Med Ped Oncol 1987; 15:236–240.
Sieber F, Rao S, Rowley SD, Sieber-Blum M. Dye-mediated photolysis of human neuroblastoma cells: Implications for autologous bone marrow transplantation. Blood 1986; 68:32–36.
Sieber F, Sieber-Blum M. Dye-mediated photosensitization of murine neuroblastoma cells. Cancer Res 1986; 46:2072–2076.
Aptzpodien J, Gulati SC, Strife A, Clarkson BD. Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts. Blood 1987; 70:484–489.
Dulley FL, Kanfer EJ, Appelbaum FR, Amos D, Hill RS, Buckner CD, Shulman HM, McDonald GB, Thomas ED. Venoocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. Transplantation 1987; 43:870–873.
Shulman HM, McDonald GB, Matthews D, Doney KC, Kopecky KJ, Gauvreau JM, Thomas ED. An analysis of hepatic venoocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 1980; 79:1178–1191.
Murray JA, LaBrecque DR, Gingrich RD, Pringle KC, Mitros FA. Successful treatment of hepatic venocclusive disease in bone marrow transplant patient with side-to-side portacaval shunt. Gastroenterology 1987; 92:1073–1077.
Valteau D, Hartmann O, Benhamou E, Caillaud JM, Brugieres L, Beaujean F, Patte C, Flamant F, Leerle J. Nonbacterial nonfungal interstitial pneumonitis following autologous bone marrow transplantation in children treated with high-dose chemotherapy without total-body irradiation. Transplantation 1988; 45:737–740.
Pritchard J, McElwain TJ, Graham-Pole J. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution. Br J Cancer 1982; 45:86–94.
Hartmann O, Kalifa C, Benhamou E, Patte C, Flamant F, Jullien C, Beaujean F, Lemerle. Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation. Cancer Chemother Pharmacol 1986; 16:165–169.
Pinkerton R, Pritchard J, deKraker J, Jones D, Germond S, Love S. ENSG 1-randomized study of high-dose melphalan in neuroblastoma. In: Autologous Marrow Transplantation: Proceedings of the Third International Symposium, Dicke KA, Spitzer G, Jagannath S, ed. MD Anderson Hospital and Tumor Institute, Houston, 1987:401–405.
Seeger RC, Reynolds CP, Moss TJ, Lenarsky C, Feig SA, Selch M, Ugelstad J, Wells J. Autologous bone marrow transplantation for poor-prognosis neuroblastoma. In: Autologous Marrow Transplantation: Proceedings of the Third International Symposium, Dicke KA, Spitzer G, Jagannath S, eds. MD Anderson Hospital and Tumor Institute, Houston, 1987:375–382.
August CS, Serota FT, Koch PA, Burkey E, Schlesinger H, Elkins WL, Evans AE, D’Angio GJ. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution. J Clin Oncol 1984; 2:609–616.
August CS, Bayever E, Levy Y, et al. Eight years’ experience in neuroblastoma patients transplanted after relapse. Proc Am Assoc Cancer Res 1986; 27:203.
Evans AE. Melphalan therapy for children with metastatic neuroblastoma. Cancer Treat Rep 1958; 52:293–296.
Hartmann O, Benhamou E, Beaujean F, Pico JL, Kalifa C, Flamant F, Lemerle J. High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: A phase II study. J Clin Oncol 1986; 4:1804–1810.
Stein J, Strandjord S, Saarinen U, Warkentin P, Gerson S, Lazarus H, Von Hoff D, Coccia P, Cheung N-K. In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: A pilot study. Prog Clin Biol Res 1988; 271:237–248.
Lazarus HM, Reed MD, Spitzer TR, Rabaa S, Blumer JL, High-dose iv thiotepa and cryopreserved autologous bone marrow transplantation for therapy of refractory cancer. Cancer Treat Rep 1987; 71:689–695.
Hayes FA, Thompson EI, Parvey L, Rao B, Kun L, Parham D, Hustu HO. Metastatic Ewing’s sarcoma: Remission induction and survival. J Clin Oncol 1987; 5:1199–1204.
Pinkerton R, Philip T, Bouffet E, Lashford L, Kemshead J. Autologous bone marrow transplantation in paediatric solid tumours. Clin Hematol 1986; 15:187–203.
Graham-Pole J, Lazarus HM, Herzig RH, Gross S, Coccia P, Weiner R, Strandjord S. High-dose melphalan therapy for treatment of children with refractory neuroblastoma and Ewing’s sarcoma. Am J Ped Hematol/Oncol 1984; 6:17–26.
Cornbleet MA, Corringham RET, Prentice HG, Boesen EM, McElwain TJ. Treatment of Ewing’s sarcoma with high-dose melphalan and autologous bone marrow transplantation. Cancer Treat Rep 1981; 65:241–244.
Miser J. Personal Communication.
Houghton JA, Cook RL, Pamela JL, Houghton PJ, Melphalan: A potential new agent in the treatment of childhood rhabdomyosarcoma. Cancer Treat Rep 1985; 69:91–96.
Hara T, Miyazaki S, Ishii E, Yoshida N, Inaba K, Ikeda K, Goya N. High-dose l-(amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-ntirosurea hydrochloride (ACNU) with autologous bone marrow rescue for patients with brain stem gliomas. Child’s Brain 1984; 11:369–374.
Hildebrand J, Badjou R, Collard-Ronge E, Delforge A, Malarme M, Spiro T, Sztern B, Vandensteene A, Stryckmans PA. Treatment of brain gliomas with high does of CCNU and autologous bone marrow transplantation. Biomed 1980; 32:71–75.
Wolff SN, Phillips GL, Herzig GP. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system. Cancer Treat Rep 1987; 71:183–185.
Giannone L, Wolff SN. Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation. Cancer Treat Rep 1987; 71:759–761.
Baumgartner C, Bleher EA, Brun del Re G, Bucher U, Deubelbeiss KA, Greiner R, Hirt A, Imbach P, Luthy A, Odavic R, Wagner HP. Autologous bone marrow transplantation in the treatment of children and adolescents with advanced malignant tumors. Med Ped Oncol 1984; 104–111.
Ekert H, Tiedemann K, Waters KD, Ellis WM. Experience with high dose multiagent chemotherapy and autologous bone marrow rescue in the treatment of twenty-two children with advanced tumours. Aust Paed J 1984; 20:195–201.
Saleh RA, Gross A, Cassano W, Gee A. Metastatic retinoblastoma successfully treated with immunomagnetic purged autologous bone marrow transplantation. Cancer 1988; 62:2301–2303.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Kluwer Academic Publishers
About this chapter
Cite this chapter
Moss, T.J. (1995). Bone marrow transplantation for solid tumors in pediatrics. In: Champlin, R. (eds) Bone Marrow Transplantation. Cancer Treatment and Research, vol 50. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1493-6_16
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1493-6_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8803-9
Online ISBN: 978-1-4613-1493-6
eBook Packages: Springer Book Archive